Disposition of captopril in normal subjects

Clinical Pharmacology and Therapeutics
K J KripalaniB H Migdalof

Abstract

The disposition of captopril, an angiotensin-converting enzyme inhibitor with antihypertensive properties, was studied in 10 normal male subjects after a single 100-mg tablet of 35S-labeled drug. Average absorption parameters for unchanged captopril in blood were Tmax 0.93 +/- 0.08 hr and Cmax 800 +/- 76 ng/ml. For total radioactivity in blood the values were Tmax 1.05 +/- 0.08 hr and Cmax 1,580 +/- 90 ng/ml (as captopril equivalents). Because of the curvilinearity of the semilogarithmic plots of blood concentrations of captopril:time, elimination half-life (t1/2) of unchanged drug could not be determined. At 1 hr unchanged captopril accounted for about 52% of total radioactivity in blood, and the dimeric disulfide metabolite of captopril accounted for about 10%. In the first 5 days after dosing, an average of about 68% of the radioactive dose was recovered in urine and 18% in feces. The distribution of radioactivity in the first 24-hr urine sample (66% of the dose) was 58% captopril (38% of dose), 2% captopril disulfide (1.5% of dose), and 40% unidentified polar metabolites (26% of dose).

Citations

Jan 1, 1987·Pharmacotherapy·M BorekW Frishman
May 1, 1988·Drug Intelligence & Clinical Pharmacy·G M Armayor, L M Lopez
Jan 1, 1986·Clinical and Experimental Hypertension. Part A, Theory and Practice·A R SinaikoB L Mirkin
Sep 1, 1982·British Journal of Clinical Pharmacology·E H UlmJ L Schelling
Feb 1, 1982·Klinische Wochenschrift·G Liebau
Apr 1, 1983·British Journal of Clinical Pharmacology·A W KelmanJ A Millar
Jan 1, 1984·Drug Metabolism Reviews·B H MigdalofK J Kripalani
Aug 6, 2008·Expert Opinion on Drug Metabolism & Toxicology·Albert W Dreisbach, Juan J L Lertora
Jun 1, 1988·British Journal of Clinical Pharmacology·B JacksonC I Johnston
Jan 1, 1984·British Journal of Clinical Pharmacology·R O DaviesJ F Walker
Nov 1, 1981·Hypertension·M J AntonaccioD Kotler
Apr 1, 1986·Journal of Clinical Pharmacology·W A CreaseyA A Sugerman
Mar 1, 1984·British Journal of Clinical Pharmacology·C RicherJ F Giudicelli
Oct 1, 1982·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·C E ItaB H Migdalof
Sep 1, 1989·British Journal of Pharmacology·P D HemsworthT J Campbell
Jan 28, 1982·The New England Journal of Medicine·D G VidtF M Fouad
Aug 22, 2006·Journal of Clinical Pharmacology·Jaclyn M LeBlancJerome J Schentag
Jan 6, 2006·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Kazuo NakagawaYukari Nishikawa
May 1, 1990·DICP : the Annals of Pharmacotherapy·J J RaiaC R Lacy
Feb 1, 1992·British Journal of Clinical Pharmacology·J R WadeH L Elliott
Feb 1, 1982·Journal of Clinical Pharmacology·S M SinghviB H Migdalof
Jan 1, 1988·European Journal of Clinical Pharmacology·W A CreaseyD A Willard
Oct 21, 1983·Pharmaceutisch Weekblad. Scientific Edition·P A Van ZwietenP B Timmermans
Jan 22, 2003·Seminars in Dialysis·Albert W Dreisbach, Juan J L Lertora
May 1, 1984·Arthritis and Rheumatism·M M ReidenbergB Lorenzo
Jan 1, 1982·British Journal of Clinical Pharmacology·A Mimran, B Jover
Nov 16, 2017·Food & Function·Weilin Shen, Toshiro Matsui
Apr 28, 2019·Journal of Cancer Research and Clinical Oncology·Erlend SkagaEinar O Vik-Mo
May 1, 1991·Angiology·E L Posvar, A J Sedman
Oct 1, 1989·Journal of Clinical Pharmacy and Therapeutics·G G Skellern
Apr 1, 1989·Angiology·S C OlsonP G Welling
Jan 1, 1986·Medicinal Research Reviews·O H Drummer, B Jarrott
Apr 1, 1984·Naunyn-Schmiedeberg's Archives of Pharmacology·Y AbeK Yamamoto
Jan 1, 1990·Journal of Toxicology. Clinical Toxicology·H ParkH G Mirchandani
Dec 1, 1981·Drug Intelligence & Clinical Pharmacy·C Harris, G H Smith
Jan 1, 1985·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·A F HealdB H Migdalof
Apr 4, 1998·European Journal of Pharmacology·Z MezeiS Sonkodi

Related Concepts

Process of Absorption
Teens
Lopirin
Disulfides
Feces
Half-Life
Proline

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Related Papers

Clinical Pharmacology and Therapeutics
K L DuchinD N McKinstry
Drug Metabolism and Disposition : the Biological Fate of Chemicals
I ChuF Benoit
Journal of Clinical Pharmacology
W A CreaseyA A Sugerman
© 2021 Meta ULC. All rights reserved